Literature DB >> 25200693

Controversial issues in biliary pancreatitis: when should we perform MRCP and ERCP?

Faruk Cavdar1, Murat Yildar2, Gürkan Tellioğlu3, Melih Kara4, Metin Tilki4, Mesut İzzet Titiz4.   

Abstract

OBJECTIVES: The majority of bile duct stones (BDS) that cause acute biliary pancreatitis (ABP) pass spontaneously into the duodenum. If not passed, they worsen the prognosis or cause recurrence. Therefore, they must be treated. The purpose of this study was to assess the number and timing of spontaneous passage of BDS using magnetic resonance cholangiopancreatography (MRCP) and to determine the effect of this approach on endoscopic retrograde cholangiopancreatography (ERCP).
METHODS: Sixty patients diagnosed with ABP were evaluated prospectively. MRCP was performed between the 1st and 4th days of an acute attack in all the patients. A control MRCP was performed after 7 days in patients with MRCP-identified choledocholithiasis. Patients in whom BDS were visible on imaging or who showed no decrease in bilirubin or cholestasis enzymes underwent ERCP.
RESULTS: MRCP revealed choledocholithiasis in 20 (33%) of the 60 patients. In the control MRCP imaging, choledocholithiasis was detected in 16 of 20 (80% of those who had stone initially) patients. ERCP was performed in these patients and in 2 patients who did not have BDS on the control MRCP but whose bilirubin values and cholestatic enzyme levels had not decreased. ERCP verified choledocholithiasis in 16 of the 18 patients. The positive predictive value of MRCP was 93.7% (15/16).
CONCLUSIONS: MRCP performed in the second week in ABP patients with a nonworsening prognosis and a suspicion of choledocholithiasis will give more specific results. This will avoid unnecessary ERCP and the potential morbidity and mortality that can develop with this invasive procedure.
Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute; Choledocholithiasis; ERCP; EUS; MRCP; Pancreatitis

Mesh:

Year:  2014        PMID: 25200693     DOI: 10.1016/j.pan.2014.08.002

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  6 in total

Review 1.  Role and timing of endoscopy in acute biliary pancreatitis.

Authors:  Andrea Anderloni; Alessandro Repici
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

2.  Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.

Authors:  Hee Seung Lee; Moon Jae Chung; Jeong Youp Park; Seungmin Bang; Seung Woo Park; Si Young Song; Jae Bock Chung
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

3.  Diagnostic accuracy of ultrasound in evaluation of obstructive jaundice with MRCP as gold standard.

Authors:  Hina Hanif; Sohail Ahmed Khan; Sobia Muneer; Syed Omair Adil
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

4.  Detection of Common Bile Duct Stones in Mild Acute Biliary Pancreatitis Using Magnetic Resonance Cholangiopancreatography.

Authors:  David Aranovich; Veacheslav Zilbermints; Natalia Goldberg; Oleg Kaminsky
Journal:  Surg Res Pract       Date:  2018-10-22

5.  Intraoperative cholangiography versus magnetic resonance cholangiography in patients with mild acute biliary pancreatitis: A prospective study in a second-level hospital.

Authors:  Gustavo Angel Gómez-Torres; Jaime González-Hernández; Carlos Rene López-Lizárraga; Eliseo Navarro-Muñiz; Odeth Sherlyne Ortega-García; Francisco Manuel Bonnet-Lemus; Francisco Manuel Abarca-Rendon; Liliana Faviola De la Cerda-Trujillo
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  Endoscopic Interventions for the Early and Remission Phases of Acute Biliary Pancreatitis: What are the More Concrete and Practical Situations for Performing Them?

Authors:  Sho Hasegawa; Shinsuke Koshita; Yoshihide Kanno; Takahisa Ogawa; Toshitaka Sakai; Hiroaki Kusunose; Kensuke Kubota; Atsushi Nakajima; Yutaka Noda; Kei Ito
Journal:  Clin Endosc       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.